n-methyl-3,4-methylenedioxyamphetamine has been researched along with Brain Diseases in 18 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armitage, MC | 1 |
| Bryant, RJ | 1 |
| Page, CB | 1 |
| Kiyatkin, EA | 1 |
| Aramendi, I | 1 |
| Manzanares, W | 1 |
| Salzmann, J | 1 |
| Marie-Claire, C | 1 |
| Noble, F | 1 |
| Ramos, M | 1 |
| Goñi-Allo, B | 1 |
| Aguirre, N | 1 |
| Gouzoulis-Mayfrank, E | 1 |
| Daumann, J | 1 |
| von Wilmsdorff, M | 1 |
| Gastpar, M | 1 |
| Nielsen, JC | 1 |
| Nicholson, K | 1 |
| Pitzner-Jørgensen, BL | 1 |
| Undén, M | 1 |
| Sprague, JE | 1 |
| Huang, X | 1 |
| Kanthasamy, A | 1 |
| Nichols, DE | 1 |
| Green, AR | 1 |
| Goodwin, GM | 1 |
| Rutty, GN | 1 |
| Milroy, CM | 1 |
| Cohen, RS | 1 |
| Cocores, J | 1 |
| Scheffel, U | 1 |
| Szabo, Z | 1 |
| Mathews, WB | 1 |
| Finley, PA | 1 |
| Dannals, RF | 1 |
| Ravert, HT | 1 |
| Szabo, K | 1 |
| Yuan, J | 1 |
| Ricaurte, GA | 2 |
| Hatzidimitriou, G | 1 |
| McCann, UD | 1 |
| Bertram, M | 1 |
| Egelhoff, T | 1 |
| Schwarz, S | 1 |
| Schwab, S | 1 |
| Walker, TM | 1 |
| Davenport-Jones, JE | 1 |
| Fox, RM | 1 |
| Atterwill, CK | 1 |
| Pennypacker, KR | 1 |
| Yang, X | 1 |
| Gordon, MN | 1 |
| Benkovic, S | 1 |
| Miller, D | 1 |
| O'Callaghan, JP | 1 |
| Hurley, RA | 1 |
| Reneman, L | 1 |
| Taber, KH | 1 |
3 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Brain Diseases
| Article | Year |
|---|---|
[Acute and long-term effects of ecstasy].
Topics: Animals; Brain Diseases; Chemical and Drug Induced Liver Injury; Fever; Hallucinogens; Humans; N-Met | 2004 |
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Topics: Animals; Brain Diseases; Cognition Disorders; Hallucinogens; Humans; Memory Disorders; Mental Disord | 2006 |
[Abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Pharmacological, neuropsychiatric and behavioral aspects].
Topics: Brain Diseases; Hallucinogens; Humans; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Sub | 1995 |
15 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Brain Diseases
| Article | Year |
|---|---|
Severe hyponatremia complicated by seizure following 3,4-methylenedioxymethamphetamine ingestion.
Topics: Adolescent; Brain Diseases; Eating; Female; Fluid Therapy; Glasgow Coma Scale; Humans; Hyponatremia; | 2018 |
Brain temperature homeostasis: physiological fluctuations and pathological shifts.
Topics: Adrenergic Uptake Inhibitors; Animals; Blood-Brain Barrier; Body Temperature; Brain; Brain Diseases; | 2010 |
[Hyponatremic encephalopathy and brain death in Ecstasy (3,4-methylenedioxymethamphetamine) intoxication].
Topics: Brain Death; Brain Diseases; Female; Hallucinogens; Humans; Hyponatremia; N-Methyl-3,4-methylenediox | 2010 |
Ibotenic acid lesions of the medial prefrontal cortex block the development and expression of 3,4-methylenedioxymethamphetamine-induced behavioral sensitization in rats.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Behavior, Animal; Brain Diseases; Drug | 2005 |
[Brain functional disorders after taking Ecstasy?].
Topics: Adult; Brain Diseases; Female; Humans; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Sub | 1995 |
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Brain Diseases; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve En | 1994 |
Ecstasy and neurodegeneration.
Topics: Brain Diseases; Chronic Disease; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Nerv | 1996 |
The pathology of the ring-substituted amphetamine analogue 3,4-methylenedioxymethylamphetamine (MDMA, 'Ecstasy')
Topics: Brain Diseases; Dopamine; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin; Substance-Relat | 1997 |
Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: "Ecstasy").
Topics: Adolescent; Brain Diseases; Humans; Male; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; | 1997 |
In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.
Topics: Animals; Autoradiography; Brain; Brain Chemistry; Brain Diseases; Carbon Isotopes; Carrier Proteins; | 1998 |
Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery.
Topics: Amygdala; Animals; Axons; Brain Diseases; Catecholamines; Corpus Striatum; Female; Hippocampus; Hypo | 1999 |
Toxic leukencephalopathy following "ecstasy" ingestion.
Topics: Adult; Brain Diseases; Coma; Hallucinogens; Humans; Magnetic Resonance Imaging; Male; N-Methyl-3,4-m | 1999 |
The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biomarkers; Brain; Brain Diseases; Cytosol; Deoxyepinephrine | 1999 |
Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine- and trimethyltin-induced brain injury.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Diseases; DNA-Binding Proteins; Dopamin | 2000 |
Ecstasy in the brain: a model for neuroimaging.
Topics: Brain; Brain Diseases; Corpus Striatum; Frontal Lobe; Globus Pallidus; Hallucinogens; Magnetic Reson | 2002 |